Today, we gathered 10 selected listings from our investor database. Our team reviewed, checked, and enriched the list with the necessary data.

Here goes:

• i&i Biotech Fund — Luxembourg-based venture capital firm i&i Bio invests in innovative European life sciences companies focused on drug discoveries, medical devices, diagnostics, and digital health. The A-round investor manages over €53M and plans to back around 20 early-stage companies. The team brings experience from private equity, healthcare, and venture capital, while close cooperation with biotech incubator i&i Prague provides access to transformative Central European technologies.

• KHAN Technology Transfer Fund — Dortmund-based venture capital fund KHAN Technology Transfer Fund I focuses on early-stage life sciences investments and cooperative drug development partnerships with academic innovators across Europe. Managing €70 million, the A-round investor targets first-in-class therapies for markets with high unmet medical need. The team has experience in early-stage drug development, academic spin-offs, pharma licensing, and partnering within the biotechnology and healthcare sectors.

• Monograph Capital — London-based Monograph Capital invests in life sciences companies developing new or improved therapeutics, diagnostics, and technology-enabled healthcare business services. The A-round venture capital firm operates across London, San Francisco, and Dallas-Fort Worth, connecting opportunities in North America, the United Kingdom, and Europe. Monograph supports biotechnology and healthcare companies with deep industry relationships, operational experience, and capabilities designed to help businesses scale internationally.

• NordicNinja VC — Helsinki-based NordicNinja VC is the largest Japanese venture capital firm in Europe, backing companies addressing global carbon footprint challenges through climate tech, deeptech, and digital society innovation. The A-round investor focuses on sectors ranging from transportation and healthcare to digital infrastructure. Its team of founders and operators supports ambitious entrepreneurs building technologies aimed at shaping a more sustainable future.

• OTV — Tel Aviv-based OTV is a mid-growth stage digital health venture capital fund investing in A+ rounds with flexible check sizes. Focused on healthcare, the firm provides entrepreneurs with operational expertise gained from founding and building companies, alongside a broad network spanning industries and geographies. OTV combines investment support with hands-on experience to help digital health startups navigate growth and scaling opportunities.

• Quadrille Capital — Paris-based Quadrille Capital is an independent investment firm focused on technology and healthcare opportunities across the United States, Europe, and China. Operating as an A-round venture capital investor, the firm supports companies positioned within the healthcare and technology sectors. Quadrille Capital maintains an international investment approach, seeking growth opportunities across major global innovation ecosystems and markets.

• Seroba Life Sciences — Dublin-based Seroba Life Sciences is a venture capital firm focused on investing in breakthrough healthcare technologies. As an A-round investor operating within biotechnology and healthcare, the firm backs companies developing innovative life sciences solutions. Seroba concentrates on supporting emerging healthcare technologies with the potential to create meaningful advances across medical and life sciences markets.

• techceler8 — Dubai-based techceler8 is a venture capital firm focused on insur-tech and health-tech investments across the UAE and Saudi Arabia. The A-round investor operates across AI, machine learning, healthcare, and SaaS sectors, leveraging both capital and technology to accelerate startup growth. techceler8 supports founders seeking expansion opportunities within rapidly developing regional technology and healthcare ecosystems.

• Vesalius Biocapital Partners — Strassen-based Vesalius Biocapital Partners manages a European life sciences venture capital fund with €120 million in assets under management. The A-round investor focuses on therapeutics development, medical devices, diagnostics, and eHealth or mHealth companies across Europe. Operating within healthcare, biotechnology, and hardware sectors, the firm supports businesses advancing innovative medical and life sciences technologies.

• YZR Capital — Munich-based YZR Venture Capital is a vertical venture capital fund backing health tech entrepreneurs. Focused on healthcare investments at the A-round stage, the firm supports founders building innovative solutions across the health technology landscape. YZR Capital concentrates on identifying and supporting entrepreneurs developing technologies designed to advance and transform healthcare delivery and services.

Have a great day!

Tzakhi

PS Download our full database of 7,100+ VCs and institutional startup investors, including one year of updates: